Neratinib in Early-Stage HER2-Positive Breast Cancer

被引：1
|
作者：
Cherian, Mathew A.
Ma, Cynthia X.
机构：
来源：
BREAST DISEASES | 2015年 / 26卷 / 04期
关键词：
D O I：
10.1016/j.breastdis.2015.10.040
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：285 / 287
页数：4
相关论文
共 50 条
  • [31] Treatment of Lymph Node-Negative, Early-Stage HER2-Positive Breast Cancer
    Oguz, Arzu
    Keskin, Gul Sema
    Colak, Dilsen
    Altundag, Ozden
    Akcali, Zafer
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) : 639 - +
  • [32] Neratinib after trastuzumab in patients with HER2-positive breast cancer
    Hasegawa, Takahiro
    Uno, Hajime
    Wei, Lee-Jen
    [J]. LANCET ONCOLOGY, 2016, 17 (05): : E176 - E176
  • [33] Effect of prophylaxis or neratinib dose escalation on neratinib-associated diarrhea and tolerability in patients with HER2-positive early-stage breast cancer: Phase II CONTROL trial
    Chan, Arlene
    Hurvitz, Sara A.
    Marx, Gavin
    Ruiz-Borrego, Manuel
    Farrell, Cynthia
    Hunt, Daniel
    McCulloch, Leanne
    Chien, A. Jo
    Tripathy, Debu
    Barcenas, Carlos H.
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [34] Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer
    Marin-Aguilera, M.
    Jares, P.
    Sanfeliu, E.
    Villacampa, G.
    Hernandez-lllan, E.
    Martinez-Puchol, A. I.
    Shankar, S.
    Gonzalez-Farre, B.
    Waks, A. G.
    Braso-Maristany, F.
    Pardo, F.
    Manning, D. K.
    Abery, J. A.
    Curaba, J.
    Moon, L.
    Gordon, O.
    Galvan, P.
    Wachirakantapong, P.
    Castillo, O.
    Nee, C. M.
    Blasco, P.
    Senevirathne, T. H.
    Sirenko, V.
    Martinez-Saez, O.
    Aguirre, A.
    Krop, I. E.
    Li, Z.
    Spellman, P.
    Metzger Filho, O.
    Polyak, K.
    Michaels, P.
    Puig-Butille, J. A.
    Vivancos, A.
    Matito, J.
    Buckingham, W.
    Perou, C. M.
    Villagrasa-Gonzalez, P.
    Prat, A.
    Parker, J. S.
    Pare, L.
    [J]. ESMO OPEN, 2024, 9 (03)
  • [35] Optimal treatment of early stage HER2-positive breast cancer
    Pernas, Sonia
    Barroso-Sousa, Romualdo
    Tolaney, Sara M.
    [J]. CANCER, 2018, 124 (23) : 4455 - 4466
  • [36] Personalized treatment for early stage HER2-positive breast cancer
    Prat, A.
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [37] Matters Arising: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
    Alaa, Ahmed M.
    Harris, Adrian L.
    van der Schaar, Mihaela
    [J]. NPJ BREAST CANCER, 2023, 9 (01)
  • [38] The impact of neoadjuvant chemotherapy on overall survival in patients with early-stage HER2-positive breast cancer
    Champion, Nicholas
    Azab, Basem
    Abeysekera, Aravinda
    Kim, Sara
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 201 - 201
  • [39] Trastuzumab plus chemotherapy improves survival in early-stage HER2-positive breast cancer patients
    不详
    [J]. ONCOLOGY-NEW YORK, 2005, 19 (07): : 851 - +
  • [40] Treatment of Lymph Node-Negative, Early-Stage HER2-Positive Breast Cancer Reply
    O'Sullivan, Ciara C.
    Holmes, Eileen
    Campbell, Christine
    Bradbury, Ian
    Zujewski, Jo Anne
    Gelber, Richard D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) : 640 - +
12345